# Requirements for Child-Resistant Packaging; Requirements for Products Containing Lidocaine or Dibucaine
> **US Consumer Product Safety Commission** · Final rule. · Published 1995-04-10 · Effective 1996-04-10 · 60 FR 17992
## Document
- **Document number:** 95-8628
- **Category:** final-rule
- **Agency:** US Consumer Product Safety Commission
- **Federal Register citation:** 60 FR 17992
- **CFR reference:** 16 CFR 1700
- **Publication date:** 1995-04-10
- **Effective date:** 1996-04-10
## Abstract

Under the Poison Prevention Packaging Act of 1970, the Commission issues a rule requiring child-resistant packaging for products containing more than 5.0 milligrams (mg) of lidocaine in a single package or more than 0.5 mg of dibucaine in a single package. These requirements are issued because the Commission has determined that child-resistant packaging is required to protect children under 5 years of age from serious personal injury and serious illness resulting from ingesting such substances. Lidocaine and dibucaine are used in prescription drugs and over-the-counter drug products that are applied to the skin or mucous membranes to provide an anesthetic effect.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/1995/04/10/95-8628/requirements-for-child-resistant-packaging-requirements-for-products-containing-lidocaine-or)
---
*AI Analytics · CC0 1.0*